BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Laganà AS, Garzon S, Casarin J, Franchi M, Ghezzi F. Inositol in Polycystic Ovary Syndrome: Restoring Fertility through a Pathophysiology-Based Approach. Trends Endocrinol Metab 2018;29:768-80. [PMID: 30270194 DOI: 10.1016/j.tem.2018.09.001] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 16.5] [Reference Citation Analysis]
Number Citing Articles
1 Ali F, Manzoor U, Bhattacharya R, Bansal AK, Chandrashekharaiah KS, Singh LR, Saraswati SM, Uversky V, Dar TA. Brain Metabolite, Myo-inositol, Inhibits Catalase Activity: A Mechanism of the Distortion of the Antioxidant Defense System in Alzheimer's disease. ACS Omega 2022;7:12690-700. [PMID: 35474814 DOI: 10.1021/acsomega.1c06990] [Reference Citation Analysis]
2 Siracusa L, Napoli E, Ruberto G. Novel Chemical and Biological Insights of Inositol Derivatives in Mediterranean Plants. Molecules 2022;27:1525. [DOI: 10.3390/molecules27051525] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Laganà AS, Forte G, Bizzarri M, Kamenov ZA, Bianco B, Kaya C, Gitas G, Alkatout I, Terzic M, Unfer V. Inositols in the ovaries: activities and potential therapeutic applications. Expert Opin Drug Metab Toxicol 2022;18:123-33. [PMID: 35472446 DOI: 10.1080/17425255.2022.2071259] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Skoracka K, Ratajczak AE, Rychter AM, Dobrowolska A, Krela-Kaźmierczak I. Female Fertility and the Nutritional Approach: The Most Essential Aspects. Adv Nutr 2021;12:2372-86. [PMID: 34139003 DOI: 10.1093/advances/nmab068] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
5 Nordio M, Kumanov P, Chiefari A, Puliani G. D-Chiro-Inositol improves testosterone levels in older hypogonadal men with low-normal testosterone: a pilot study. Basic Clin Androl 2021;31:28. [PMID: 34763665 DOI: 10.1186/s12610-021-00146-4] [Reference Citation Analysis]
6 Zheng B, Meng J, Zhu Y, Ding M, Zhang Y, Zhou J. Melatonin enhances SIRT1 to ameliorate mitochondrial membrane damage by activating PDK1/Akt in granulosa cells of PCOS. J Ovarian Res 2021;14:152. [PMID: 34758863 DOI: 10.1186/s13048-021-00912-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Vitagliano A, Petre GC, Francini-Pesenti F, De Toni L, Di Nisio A, Grande G, Foresta C, Garolla A. Dietary Supplements for Female Infertility: A Critical Review of Their Composition. Nutrients 2021;13:3552. [PMID: 34684554 DOI: 10.3390/nu13103552] [Reference Citation Analysis]
8 Maleki V, Faghfouri AH, Tabrizi FPF, Moludi J, Saleh-Ghadimi S, Jafari-Vayghan H, Qaisar SA. Mechanistic and therapeutic insight into the effects of cinnamon in polycystic ovary syndrome: a systematic review. J Ovarian Res 2021;14:130. [PMID: 34627352 DOI: 10.1186/s13048-021-00870-5] [Reference Citation Analysis]
9 Abdelrahman A, Mahmoud AA, Lamie Fanous Y, Abd Elhaliem NG, Elalaf H. Impact of erythropoietin and myoinositol versus metformin on insulin resistance in a rat model of polycystic ovary syndrome. Arch Physiol Biochem 2021;:1-12. [PMID: 34297646 DOI: 10.1080/13813455.2021.1949023] [Reference Citation Analysis]
10 Bizzarri M, Logoteta P, Monastra G, Laganà AS. An innovative approach to polycystic ovary syndrome. J Obstet Gynaecol 2021;:1-11. [PMID: 34169781 DOI: 10.1080/01443615.2021.1920006] [Reference Citation Analysis]
11 Monastra G, Vazquez-Levin M, Bezerra Espinola MS, Bilotta G, Laganà AS, Unfer V. D-chiro-inositol, an aromatase down-modulator, increases androgens and reduces estrogens in male volunteers: a pilot study. Basic Clin Androl 2021;31:13. [PMID: 34078260 DOI: 10.1186/s12610-021-00131-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Iervolino M, Lepore E, Forte G, Laganà AS, Buzzaccarini G, Unfer V. Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review. Nutrients 2021;13:1677. [PMID: 34063339 DOI: 10.3390/nu13051677] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Zhang J, Xing C, Zhao H, He B. The effectiveness of coenzyme Q10, vitamin E, inositols, and vitamin D in improving the endocrine and metabolic profiles in women with polycystic ovary syndrome: a network Meta-analysis. Gynecol Endocrinol 2021;:1-9. [PMID: 33988478 DOI: 10.1080/09513590.2021.1926975] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
14 Huang Y, Zhang X. Luteolin alleviates polycystic ovary syndrome in rats by resolving insulin resistance and oxidative stress. Am J Physiol Endocrinol Metab 2021;320:E1085-92. [PMID: 33900851 DOI: 10.1152/ajpendo.00034.2021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
15 Monastra G, Vucenik I, Harrath AH, Alwasel SH, Kamenov ZA, Laganà AS, Monti N, Fedeli V, Bizzarri M. PCOS and Inositols: Controversial Results and Necessary Clarifications. Basic Differences Between D-Chiro and Myo-Inositol. Front Endocrinol (Lausanne) 2021;12:660381. [PMID: 33889133 DOI: 10.3389/fendo.2021.660381] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Almalki WH. A review on inositol's potential in cyclic disturbances of adipose-endocrinology-associated polycystic ovary syndrome. Mol Cell Biochem 2021;476:2943-9. [PMID: 33755878 DOI: 10.1007/s11010-021-04123-3] [Reference Citation Analysis]
17 Ye W, Deng G, Yin L, Ye J. Efficacy and safety of moxibustion in the treatment of infertility with polycystic ovary syndrome: A protocol of systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e24529. [PMID: 33725936 DOI: 10.1097/MD.0000000000024529] [Reference Citation Analysis]
18 Yi S, Xu J, Shi H, Li W, Li Q, Sun YP. Association between melatonin receptor gene polymorphisms and polycystic ovarian syndrome: a systematic review and meta-analysis. Biosci Rep 2020;40:BSR20200824. [PMID: 32463080 DOI: 10.1042/BSR20200824] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Gong W, Bilixzi A, Wang X, Lu Y, Wan L, Han L. The role of serum β-trophin and endostatin in patients with polycystic ovary syndrome: Are they correlated? BMC Womens Health 2021;21:104. [PMID: 33706732 DOI: 10.1186/s12905-021-01198-4] [Reference Citation Analysis]
20 Ma Y, Ma L, Cao Y, Zhai J. Construction of a ceRNA-based lncRNA-mRNA network to identify functional lncRNAs in polycystic ovarian syndrome. Aging (Albany NY) 2021;13:8481-96. [PMID: 33714202 DOI: 10.18632/aging.202659] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Gonzalez-Uarquin F, Sommerfeld V, Rodehutscord M, Huber K. Interrelationship of myo-inositol pathways with systemic metabolic conditions in two strains of high-performance laying hens during their productive life span. Sci Rep 2021;11:4641. [PMID: 33633252 DOI: 10.1038/s41598-021-84169-x] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
22 Liu C, Yue S, Solarz J, Lee J, Li L. Improving the sexual activity and reproduction of female zebrafish with high testosterone levels. Sci Rep 2021;11:3822. [PMID: 33589678 DOI: 10.1038/s41598-021-83085-4] [Reference Citation Analysis]
23 Merviel P, James P, Bouée S, Le Guillou M, Rince C, Nachtergaele C, Kerlan V. Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies. Reprod Health 2021;18:13. [PMID: 33468143 DOI: 10.1186/s12978-021-01073-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Bezerra Espinola MS, Bertelli M, Bizzarri M, Unfer V, Laganà AS, Visconti B, Aragona C. Inositol and vitamin D may naturally protect human reproduction and women undergoing assisted reproduction from Covid-19 risk. J Reprod Immunol 2021;144:103271. [PMID: 33493945 DOI: 10.1016/j.jri.2021.103271] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Khafagy G, El Sayed I, Abbas S, Soliman S. Perceived Stress Scale Among Adolescents with Polycystic Ovary Syndrome. Int J Womens Health 2020;12:1253-8. [PMID: 33402850 DOI: 10.2147/IJWH.S279245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Aly JM, Decherney AH. Lifestyle Modifications in PCOS. Clin Obstet Gynecol 2021;64:83-9. [PMID: 33346595 DOI: 10.1097/GRF.0000000000000594] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Szczuko M, Kikut J, Komorniak N, Bilicki J, Celewicz Z, Ziętek M. The Role of Arachidonic and Linoleic Acid Derivatives in Pathological Pregnancies and the Human Reproduction Process. Int J Mol Sci 2020;21:E9628. [PMID: 33348841 DOI: 10.3390/ijms21249628] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Wang C, Yue S, Jiang Y, Mao Y, Zhao Z, Liu X, Zhang X, Pei D, Li Y. LncRNA GAS5 is upregulated in polycystic ovary syndrome and regulates cell apoptosis and the expression of IL-6. J Ovarian Res 2020;13:145. [PMID: 33308258 DOI: 10.1186/s13048-020-00748-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
29 Palomba S, Piltonen TT, Giudice LC. Endometrial function in women with polycystic ovary syndrome: a comprehensive review. Hum Reprod Update 2021;27:584-618. [PMID: 33302299 DOI: 10.1093/humupd/dmaa051] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
30 Safi A, Orazov M, Kalinchenko S. The role of cholecalciferol deficiency in the pathogenesis of polycystic ovary syndrome. Womens Health (Lond) 2020;16:1745506520969606. [PMID: 33226913 DOI: 10.1177/1745506520969606] [Reference Citation Analysis]
31 Facchinetti F, Cavalli P, Copp AJ, D'Anna R, Kandaraki E, Greene NDE, Unfer V; Experts Group on Inositol in Basic and Clinical Research. An update on the use of inositols in preventing gestational diabetes mellitus (GDM) and neural tube defects (NTDs). Expert Opin Drug Metab Toxicol. 2020;16:1187-1198. [PMID: 32966143 DOI: 10.1080/17425255.2020.1828344] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
32 Luque-Ramírez M, Ortiz-Flores AE, Nattero-Chávez L, Escobar-Morreale HF. A safety evaluation of current medications for adult women with the polycystic ovarian syndrome not pursuing pregnancy. Expert Opin Drug Saf 2020;19:1559-76. [PMID: 33070640 DOI: 10.1080/14740338.2020.1839409] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Pani A, Giossi R, Menichelli D, Fittipaldo VA, Agnelli F, Inglese E, Romandini A, Roncato R, Pintaudi B, Del Sole F, Scaglione F. Inositol and Non-Alcoholic Fatty Liver Disease: A Systematic Review on Deficiencies and Supplementation. Nutrients 2020;12:E3379. [PMID: 33153126 DOI: 10.3390/nu12113379] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
34 Santoro M, Aquila S, Russo G. Sperm performance in oligoasthenoteratozoospermic patients is induced by a nutraceuticals mix, containing mainly myo-inositol. Syst Biol Reprod Med 2021;67:50-63. [PMID: 33094655 DOI: 10.1080/19396368.2020.1826067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
35 Kim SY, Park ES, Kim HW. Effectiveness of Non-Pharmacological Interventions for Overweight or Obese Infertile Women: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health 2020;17:E7438. [PMID: 33066039 DOI: 10.3390/ijerph17207438] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Barger MK. Current Resources for Evidence‐Based Practice, September/October 2020. Journal of Midwifery & Women's Health 2020;65:705-12. [DOI: 10.1111/jmwh.13169] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Aksu K, Akincioglu H, Gulcin I, Kelebekli L. Concise syntheses and some biological activities of dl-2,5-di-O-methyl-chiro-inositol, dl-1,4-di-O-methyl-scyllo-inositol, and dl-1,6-dibromo-1,6-dideoxy-2,5-di-O-methyl-chiro-inositol. Arch Pharm (Weinheim) 2021;354:e2000254. [PMID: 32997390 DOI: 10.1002/ardp.202000254] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Unfer V, Dinicola S, Laganà AS, Bizzarri M. Altered Ovarian Inositol Ratios May Account for Pathological Steroidogenesis in PCOS. Int J Mol Sci 2020;21:E7157. [PMID: 32998310 DOI: 10.3390/ijms21197157] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
39 Wawrzkiewicz-Jałowiecka A, Kowalczyk K, Trybek P, Jarosz T, Radosz P, Setlak M, Madej P. In Search of New Therapeutics-Molecular Aspects of the PCOS Pathophysiology: Genetics, Hormones, Metabolism and Beyond. Int J Mol Sci 2020;21:E7054. [PMID: 32992734 DOI: 10.3390/ijms21197054] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
40 Laganà AS, Unfer V, Garzon S, Bizzarri M. Role of inositol to improve surfactant functions and reduce IL-6 levels: A potential adjuvant strategy for SARS-CoV-2 pneumonia? Med Hypotheses 2020;144:110262. [PMID: 33254564 DOI: 10.1016/j.mehy.2020.110262] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
41 Aversa A, La Vignera S, Rago R, Gambineri A, Nappi RE, Calogero AE, Ferlin A. Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions. Front Endocrinol (Lausanne) 2020;11:516. [PMID: 32849300 DOI: 10.3389/fendo.2020.00516] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
42 De Diego MV, Gómez-pardo O, Groar JK, López-escobar A, Martín-estal I, Castilla-cortázar I, Rodríguez-zambrano MÁ. Metabolic impact of current therapeutic strategies in Polycystic Ovary Syndrome: a preliminary study. Arch Gynecol Obstet 2020;302:1169-79. [DOI: 10.1007/s00404-020-05696-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
43 Idicula-Thomas S, Gawde U, Bhaye S, Pokar K, Bader GD. Meta-analysis of gene expression profiles of lean and obese PCOS to identify differentially regulated pathways and risk of comorbidities. Comput Struct Biotechnol J 2020;18:1735-45. [PMID: 32695266 DOI: 10.1016/j.csbj.2020.06.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Laganà AS, Garzon S, Unfer V. New clinical targets of d-chiro-inositol: rationale and potential applications. Expert Opin Drug Metab Toxicol 2020;16:703-10. [PMID: 32552009 DOI: 10.1080/17425255.2020.1785429] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
45 Kikut J, Komorniak N, Ziętek M, Palma J, Szczuko M. Inflammation with the participation of arachidonic (AA) and linoleic acid (LA) derivatives (HETEs and HODEs) is necessary in the course of a normal reproductive cycle and pregnancy. J Reprod Immunol 2020;141:103177. [PMID: 32659532 DOI: 10.1016/j.jri.2020.103177] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
46 Tsiaka T, Fotakis C, Lantzouraki DZ, Tsiantas K, Siapi E, Sinanoglou VJ, Zoumpoulakis P. Expanding the Role of Sub-Exploited DOE-High Energy Extraction and Metabolomic Profiling towards Agro-Byproduct Valorization: The Case of Carotenoid-Rich Apricot Pulp. Molecules 2020;25:E2702. [PMID: 32545179 DOI: 10.3390/molecules25112702] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
47 Siracusa L, Occhiuto C, Molonia MS, Cimino F, Palumbo M, Saija A, Speciale A, Rocco C, Ruberto G, Cristani M. A pinitol-rich Glycyrrhiza glabra L. leaf extract as functional supplement with potential in the prevention of endothelial dysfunction through improving insulin signalling. Arch Physiol Biochem 2020;:1-10. [PMID: 32476488 DOI: 10.1080/13813455.2020.1764046] [Reference Citation Analysis]
48 Facchinetti F, Unfer V, Dewailly D, Kamenov ZA, Diamanti-kandarakis E, Laganà AS, Nestler JE, Soulage CO. Inositols in Polycystic Ovary Syndrome: An Overview on the Advances. Trends in Endocrinology & Metabolism 2020;31:435-47. [DOI: 10.1016/j.tem.2020.02.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 13.5] [Reference Citation Analysis]
49 Cozzolino M, Vitagliano A, Pellegrini L, Chiurazzi M, Andriasani A, Ambrosini G, Garrido N. Therapy with probiotics and synbiotics for polycystic ovarian syndrome: a systematic review and meta-analysis. Eur J Nutr 2020;59:2841-56. [DOI: 10.1007/s00394-020-02233-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Raei Sadigh A, Darabi M, Salmassi A, Hamdi K, Farzadi L, Ghasemzadeh A, Fattahi A, Nouri M. Fractalkine and apoptotic/anti-apoptotic markers in granulosa cells of women with polycystic ovarian syndrome. Mol Biol Rep 2020;47:3593-603. [PMID: 32350744 DOI: 10.1007/s11033-020-05452-0] [Reference Citation Analysis]
51 Jabbour R, Ott J, Eppel W, Frigo P. Carotid intima-media thickness in polycystic ovary syndrome and its association with hormone and lipid profiles. PLoS One 2020;15:e0232299. [PMID: 32330202 DOI: 10.1371/journal.pone.0232299] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
52 Fruzzetti F, Benelli E, Fidecicchi T, Tonacchera M. Clinical and Metabolic Effects of Alpha-Lipoic Acid Associated with Two Different Doses of Myo-Inositol in Women with Polycystic Ovary Syndrome. Int J Endocrinol 2020;2020:2901393. [PMID: 32256570 DOI: 10.1155/2020/2901393] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
53 Facchinetti F, Appetecchia M, Aragona C, Bevilacqua A, Bezerra Espinola MS, Bizzarri M, D'Anna R, Dewailly D, Diamanti-Kandarakis E, Hernández Marín I, Kamenov ZA, Kandaraki E, Laganà AS, Monastra G, Montanino Oliva M, Nestler JE, Orio F, Ozay AC, Papalou O, Pkhaladze L, Porcaro G, Prapas N, Soulage CO, Stringaro A, Wdowiak A, Unfer V. Experts' opinion on inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: a further help for human reproduction and beyond. Expert Opin Drug Metab Toxicol 2020;16:255-74. [PMID: 32129111 DOI: 10.1080/17425255.2020.1737675] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 13.5] [Reference Citation Analysis]
54 Tian S, Dong W, Chan KL, Leng X, Bedford LE, Liu J. Screening for chronic conditions with reproductive factors using a machine learning based approach. Sci Rep 2020;10:2848. [PMID: 32071372 DOI: 10.1038/s41598-020-59825-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Cirillo F, Catellani C, Lazzeroni P, Sartori C, Tridenti G, Vezzani C, Fulghesu AM, Madeddu E, Amarri S, Street ME. HMGB1 is increased in adolescents with polycystic ovary syndrome (PCOS) and decreases after treatment with myo-inositol (MYO) in combination with alpha-lipoic acid (ALA). Gynecological Endocrinology 2020;36:588-93. [DOI: 10.1080/09513590.2020.1725967] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
56 Luo M, Huang JC, Yang ZQ, Wang YS, Guo B, Yue ZP. Hydroxysafflor yellow A exerts beneficial effects by restoring hormone secretion and alleviating oxidative stress in polycystic ovary syndrome mice. Exp Physiol 2020;105:282-92. [PMID: 31803965 DOI: 10.1113/EP088147] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
57 Zhang X, Zheng Y, Guo Y, Lai Z. The Effect of Low Carbohydrate Diet on Polycystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials. Int J Endocrinol 2019;2019:4386401. [PMID: 31885557 DOI: 10.1155/2019/4386401] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 8.7] [Reference Citation Analysis]
58 Chhetri DR. Myo-Inositol and Its Derivatives: Their Emerging Role in the Treatment of Human Diseases. Front Pharmacol 2019;10:1172. [PMID: 31680956 DOI: 10.3389/fphar.2019.01172] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 8.3] [Reference Citation Analysis]
59 Sidra S, Tariq MH, Farrukh MJ, Mohsin M. Evaluation of clinical manifestations, health risks, and quality of life among women with polycystic ovary syndrome. PLoS One 2019;14:e0223329. [PMID: 31603907 DOI: 10.1371/journal.pone.0223329] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
60 de Assis Rodrigues NP, Laganà AS, Zaia V, Vitagliano A, Barbosa CP, de Oliveira R, Trevisan CM, Montagna E. The role of Kisspeptin levels in polycystic ovary syndrome: a systematic review and meta-analysis. Arch Gynecol Obstet 2019;300:1423-34. [DOI: 10.1007/s00404-019-05307-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
61 Garzon S, Laganà AS, Monastra G. Risk of reduced intestinal absorption of myo-inositol caused by D-chiro-inositol or by glucose transporter inhibitors. Expert Opinion on Drug Metabolism & Toxicology 2019;15:697-703. [DOI: 10.1080/17425255.2019.1651839] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
62 Advani K, Batra M, Tajpuriya S, Gupta R, Saraswat A, Nagar HD, Makwana L, Kshirsagar S, Kaul P, Ghosh AK, Pradhan S, Mehta A, Jaiswal A, Nakhate KT, Kamdi S. Efficacy of combination therapy of inositols, antioxidants and vitamins in obese and non-obese women with polycystic ovary syndrome: an observational study. J Obstet Gynaecol 2020;40:96-101. [PMID: 31339394 DOI: 10.1080/01443615.2019.1604644] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
63 Nikishin DA, Alyoshina NM, Semenova ML, Shmukler YB. Analysis of Expression and Functional Activity of Aromatic L-Amino Acid Decarboxylase (DDC) and Serotonin Transporter (SERT) as Potential Sources of Serotonin in Mouse Ovary. Int J Mol Sci 2019;20:E3070. [PMID: 31234589 DOI: 10.3390/ijms20123070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
64 Li Y, Chen C, Ma Y, Xiao J, Luo G, Li Y, Wu D. Multi-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS). Life Sci 2019;228:167-75. [PMID: 31029778 DOI: 10.1016/j.lfs.2019.04.046] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
65 Li Z, Peng A, Feng Y, Zhang X, Liu F, Chen C, Ye X, Qu J, Jin C, Wang M, Qiu H, Qi Y, Huang J, Yang Q. Detection of T lymphocyte subsets and related functional molecules in follicular fluid of patients with polycystic ovary syndrome. Sci Rep 2019;9:6040. [PMID: 30988342 DOI: 10.1038/s41598-019-42631-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
66 Wu Z, Dong Y, Ma Y, Li Y, Li L, Lin N, Li Y, Zhuan L, Bai Y, Luo X, Kang X. Progesterone elevation on the day of hCG trigger has detrimental effect on live birth rate in low and intermediate ovarian responders, but not in high responders. Sci Rep 2019;9:5127. [PMID: 30914679 DOI: 10.1038/s41598-019-41499-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
67 Sinha P, Chitra T, Papa D, Nandeesha H. Laparoscopic Ovarian Drilling Reduces Testosterone and Luteinizing Hormone/Follicle-Stimulating Hormone Ratio and Improves Clinical Outcome in Women with Polycystic Ovary Syndrome. J Hum Reprod Sci 2019;12:224-8. [PMID: 31576080 DOI: 10.4103/jhrs.JHRS_161_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
68 Vitagliano A, Saccone G, Cosmi E, Visentin S, Dessole F, Ambrosini G, Berghella V. Inositol for the prevention of gestational diabetes: a systematic review and meta-analysis of randomized controlled trials. Arch Gynecol Obstet 2019;299:55-68. [DOI: 10.1007/s00404-018-5005-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
69 Laganà AS, Vitale SG, Noventa M, Vitagliano A. Current Management of Polycystic Ovary Syndrome: From Bench to Bedside. Int J Endocrinol 2018;2018:7234543. [PMID: 30538744 DOI: 10.1155/2018/7234543] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]